Literature DB >> 2117205

A multicenter randomized controlled clinical trial of bovine surfactant for prevention of respiratory distress syndrome.

L Gortner1, U Bernsau, H H Hellwege, G Hieronimi, G Jorch, H L Reiter.   

Abstract

Treatment with bovine surfactant (SF-RI 1) was shown to be efficacious in improving pulmonary function and in increasing survival rate without BPD in very premature infants. Surfactant therapy did not affect the risk of major complications of prematurity.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2117205     DOI： 10.1007/bf02718221

Source DB:  PubMed          Journal:  Lung        ISSN： 0341-2040            Impact factor:   2.584


  15 in total

1.  Surfactant replacement therapy for severe neonatal respiratory distress syndrome: an international randomized clinical trial. Collaborative European Multicenter Study Group.

Authors: 
Journal:  Pediatrics       Date:  1988-11       Impact factor: 7.124

Review 2.  Surfactant replacement. A new era with many challenges for neonatal medicine.

Authors:  T A Merritt; M Hallman
Journal:  Am J Dis Child       Date:  1988-12

3.  Randomized controlled trial of exogenous surfactant for the treatment of hyaline membrane disease.

Authors:  J D Gitlin; R F Soll; R B Parad; J D Horbar; H A Feldman; J F Lucey; H W Taeusch
Journal:  Pediatrics       Date:  1987-01       Impact factor: 7.124

Review 4.  Surfactant for the treatment of respiratory distress syndrome.

Authors:  A Jobe; M Ikegami
Journal:  Am Rev Respir Dis       Date:  1987-11

5.  Double-blind controlled trial of single-dose treatment with bovine surfactant in severe hyaline membrane disease.

Authors:  T N Raju; D Vidyasagar; R Bhat; D Sobel; K M McCulloch; M Anderson; H Maeta; P S Levy; S Furner
Journal:  Lancet       Date:  1987-03-21       Impact factor: 79.321

6.  Clinical and roentgenographic scoring systems for assessing bronchopulmonary dysplasia.

Authors:  S S Toce; P M Farrell; L A Leavitt; D P Samuels; D K Edwards
Journal:  Am J Dis Child       Date:  1984-06

7.  Prevention of neonatal respiratory distress syndrome by tracheal instillation of surfactant: a randomized clinical trial.

Authors:  G Enhorning; A Shennan; F Possmayer; M Dunn; C P Chen; J Milligan
Journal:  Pediatrics       Date:  1985-08       Impact factor: 7.124

8.  Double-blind clinical trial of calf lung surfactant extract for the prevention of hyaline membrane disease in extremely premature infants.

Authors:  M S Kwong; E A Egan; R H Notter; D L Shapiro
Journal:  Pediatrics       Date:  1985-10       Impact factor: 7.124

9.  A multicenter randomized, placebo-controlled trial of surfactant therapy for respiratory distress syndrome.

Authors:  J D Horbar; R F Soll; J M Sutherland; U Kotagal; A G Philip; D L Kessler; G A Little; W H Edwards; D Vidyasagar; T N Raju
Journal:  N Engl J Med       Date:  1989-04-13       Impact factor: 91.245

10.  Exogenous human surfactant for treatment of severe respiratory distress syndrome: a randomized prospective clinical trial.

Authors:  M Hallman; T A Merritt; A L Jarvenpaa; B Boynton; F Mannino; L Gluck; T Moore; D Edwards
Journal:  J Pediatr       Date:  1985-06       Impact factor: 4.406
View more
  7 in total

Review 1.  Colfosceril palmitate. A review of the therapeutic efficacy and clinical tolerability of a synthetic surfactant preparation (Exosurf Neonatal) in neonatal respiratory distress syndrome.

Authors:  K L Dechant; D Faulds
Journal:  Drugs       Date:  1991-11       Impact factor: 9.546

Review 2.  Surfactant replacement therapy.

Authors:  M J Kresch; W H Lin; R S Thrall
Journal:  Thorax       Date:  1996-11       Impact factor: 9.139

Review 3.  Natural vs synthetic surfactants in neonatal respiratory distress syndrome.

Authors:  H L Halliday
Journal:  Drugs       Date:  1996-02       Impact factor: 9.546

4.  Effects of cholesterol on the structure and collapse of DPPC monolayers.

Authors:  Fazle R Dayeen; Bret A Brandner; Michael W Martynowycz; Kamil Kucuk; Michael J Foody; Wei Bu; Stephen B Hall; David Gidalevitz
Journal:  Biophys J       Date:  2022-07-14       Impact factor: 3.699

Review 5.  Pulmonary surfactant therapy.

Authors:  F R Poulain; J A Clements
Journal:  West J Med       Date:  1995-01

Review 6.  Alveolar lipids in pulmonary disease. A review.

Authors:  Christina W Agudelo; Ghassan Samaha; Itsaso Garcia-Arcos
Journal:  Lipids Health Dis       Date:  2020-06-03       Impact factor: 3.876

Review 7.  The surfactant system of the adult lung: physiology and clinical perspectives.

Authors:  H Hamm; H Fabel; W Bartsch
Journal:  Clin Investig       Date:  1992-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.